D. E. Shaw Research (DESRES) is a New York-based drug discovery and computational biochemistry research company developing and using advanced computational technologies to understand the behavior of biologically and pharmaceutically significant molecules at an atomic level of detail, and to design precisely targeted, highly selective drugs for the treatment of various diseases. Among our core technologies is a proprietary special-purpose supercomputer called ANTON® which we designed and constructed to perform molecular dynamics simulations more than 100 times faster than the world's fastest general-purpose supercomputers. DESRES develops and refines advanced biomolecular modeling methods, software, and machine learning techniques on ANTON®, as well as on general-purpose supercomputers, in order to pursue both internal and collaborative drug discovery programs
We found 1 Daniel Lin-Arlow's email addresses
We found 1 Daniel Lin-Arlow's phone numbers
Daniel Lin-Arlow's social media include: Linkedin,
Daniel Lin-Arlow works for Ansa Biotechnologies, Inc.
Daniel Lin-Arlow's role in Ansa Biotechnologies, Inc. is Chief Executive Officer
Daniel Lin-Arlow's latest job experience is Chief Executive Officer at Ansa Biotechnologies, Inc.
Daniel Lin-Arlow's latest education in University of California, Berkeley
Daniel Lin-Arlow possesses 16.1 years of experience, specializing in undefined, currently in the role of Chief Executive Officer at Ansa Biotechnologies, Inc.. Based in Berkeley, California, United States. For more, visit LinkedIn: https://www.linkedin.com/in/daniel-lin-arlow, formerly worked at [object Object], surrounded by 84 team members, contributing to the Biotechnology Research market.